We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BASFY and ADAMA Partner to Advance Gilboa Fungicide in Europe
Read MoreHide Full Article
Key Takeaways
BASF and ADAMA agreed to co-develop Gilboa-based products to address disease resistance in Europe.
Gilboa offers a novel FRAC Group 32 mode of action targeting nucleic acid metabolism for cereals.
BASF expects Gilboa-based wheat formulations to launch in Great Britain in 2027, with Europe in 2029.
BASF SE’s (BASFY - Free Report) Agricultural Solutions unit and ADAMA Ltd. have entered into a strategic co-development and commercialization deal focused on ADAMA’s proprietary fungicide active ingredient, Gilboa (flumetylsulforim). The collaboration will accelerate the delivery of novel and advanced disease management solutions. The partnership will aim to benefit European farmers facing resistance challenges and maintain healthy yields.
Under the deal, BASF will develop and commercialize new formulations based on the Gilboa molecule, alongside ADAMA’s Gilboa-based products. The collaboration will build on ADAMA’s innovation alongwith BASF’s development expertise and strong access across Europe. Both companies will independently determine their own product concepts, pricing, sales and go-to-market strategies.
Gilboa offers a novel mode of action for cereals and is classified under the Fungicide Resistance Action Committee (FRAC) Group 32, targeting nucleic acid metabolism. The molecule provides a new solution in Europe to the challenges of high regulatory pressure and the phase-out of existing active ingredients. It is expected to support yield and quality while offering long-lasting disease control solutions.
Both companies share a commitment to innovation, sustainability and delivering quality to farmers. This collaboration will speed up access to cutting-edge fungicide technologies. Subject to approval, Gilboa-based formulations for wheat are expected to be launched by both companies in Great Britain in 2027, with wider European launches planned for 2029.
BASFY’s shares have gained 20.4% over the past year compared with the industry’s 13.9% decline.
Image Source: Zacks Investment Research
BASFY’s Zacks Rank & Key Picks
BASFY currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Kinross Gold Corporation (KGC - Free Report) , Fortuna Mining Corp. (FSM - Free Report) and Equinox Gold Corp. (EQX - Free Report) .
The Zacks Consensus Estimate for KGC’s current-year earnings is pegged at $1.67 per share, indicating a rise of 145.59%. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once, with an average surprise of 17.37%. KGC’s shares have gained 208.7% over the past year.
The Zacks Consensus Estimate for FSM’s current fiscal-year earnings is pinned at 76 cents per share, indicating a 65.22% year-over-year increase. Its shares have surged 126.4% over the past year.
The Zacks Consensus Estimate for EQX’s current-year earnings stands at 54 cents per share, implying a 170% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in two of the trailing four quarters and missed twice, with the average earnings surprise of 87%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
BASFY and ADAMA Partner to Advance Gilboa Fungicide in Europe
Key Takeaways
BASF SE’s (BASFY - Free Report) Agricultural Solutions unit and ADAMA Ltd. have entered into a strategic co-development and commercialization deal focused on ADAMA’s proprietary fungicide active ingredient, Gilboa (flumetylsulforim). The collaboration will accelerate the delivery of novel and advanced disease management solutions. The partnership will aim to benefit European farmers facing resistance challenges and maintain healthy yields.
Under the deal, BASF will develop and commercialize new formulations based on the Gilboa molecule, alongside ADAMA’s Gilboa-based products. The collaboration will build on ADAMA’s innovation alongwith BASF’s development expertise and strong access across Europe. Both companies will independently determine their own product concepts, pricing, sales and go-to-market strategies.
Gilboa offers a novel mode of action for cereals and is classified under the Fungicide Resistance Action Committee (FRAC) Group 32, targeting nucleic acid metabolism. The molecule provides a new solution in Europe to the challenges of high regulatory pressure and the phase-out of existing active ingredients. It is expected to support yield and quality while offering long-lasting disease control solutions.
Both companies share a commitment to innovation, sustainability and delivering quality to farmers. This collaboration will speed up access to cutting-edge fungicide technologies. Subject to approval, Gilboa-based formulations for wheat are expected to be launched by both companies in Great Britain in 2027, with wider European launches planned for 2029.
BASFY’s shares have gained 20.4% over the past year compared with the industry’s 13.9% decline.
Image Source: Zacks Investment Research
BASFY’s Zacks Rank & Key Picks
BASFY currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Kinross Gold Corporation (KGC - Free Report) , Fortuna Mining Corp. (FSM - Free Report) and Equinox Gold Corp. (EQX - Free Report) .
At present, KGC sports a Zacks Rank #1 (Strong Buy), while FSM and EQX carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for KGC’s current-year earnings is pegged at $1.67 per share, indicating a rise of 145.59%. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once, with an average surprise of 17.37%. KGC’s shares have gained 208.7% over the past year.
The Zacks Consensus Estimate for FSM’s current fiscal-year earnings is pinned at 76 cents per share, indicating a 65.22% year-over-year increase. Its shares have surged 126.4% over the past year.
The Zacks Consensus Estimate for EQX’s current-year earnings stands at 54 cents per share, implying a 170% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in two of the trailing four quarters and missed twice, with the average earnings surprise of 87%.